Exelixis(EXEL) - 2024 Q4 - Earnings Call Presentation
TUESDAY, FEBRUARY 11, 2025 Fourth Quarter & Fiscal Year 2024 Financial Results Business Update and Highlights Financial Results & Guidance Q&A Susan Hubbard EVP, Public Affairs and Investor Relations Michael M. Morrissey, Ph.D. President and CEO Nasdaq: EXEL Today's Agenda Introduction Chris Senner EVP and CFO Amy Peterson, M.D. EVP, Product Development and Medical Affairs and CMO Dana T. Aftab, Ph.D. EVP, Discovery and Translational Research and CSO 2 Forward-Looking Statements This presentation, including ...